At Riparian, our consulting, business process outsourcing, and software capabilities enable clients in all industry subsegments – including Top 10 to emerging; cell and gene and digital therapeutics; biologics and specialty producers; and generic and OTC manufacturers – to better understand the revenue management of their drug(s) and ensure the prices reported to the government are in compliance with current statutes and regulations of Government Pricing (“GP”) Programs.
GP Programs have an ever growing impact on financial planning, business strategy, and maintaining compliance. Calculating accurate price points, specifically, continues to be a difficult issue for manufacturers, while other challenges – including timely reporting of state price transparency information, establishing accruals, managing related software systems, and maximizing broad organizational value – all contribute to a complex network of potential launch setbacks.